吲哚布芬对急性脑梗死治疗地临床分析杨琨孙佳凡山西省中西医结合医院神经内科ClinicAnalysisofTreatmentontheAcuteIschemicStrokewithIndobufenb5E2RGbCAPYang-kunSun-jiafanDepartmentofNeurology,ShanxiProvincialHospitalofIntegratedTraditionalChineseandWesternMedicine,Taiyuan030013,China;p1EanqFDPw〔Abstract〕ObjectiveToinvestigatetheeffectsandsafetyofXinbei-(n=82)andcontrolgroup(n=88).Thepatientsinexperimentgroupweregivenanti-plateletindobufen(200mg,bid)andothersincontrolgroupweregivenaspirin(100mg,qd),:Aftertreatment,theplateletaggregationinbothgroupswerelowerat2-weekand6-weeksthanbefore(P<).Thescoreofneurologyimpairmentinthebothgroupswereimprovedatthe6-weeks(P<).Therewasnosignificantdifferenceintheplateletaggregationandthescorebetweenexperimentgroupandcontrolgroup(P>).-:Indobufen,anti-platelet,acuteischemicstrokeRTCrpUDGiT摘要:(n=82)和阳性药物对照组(n=88
吲哚布芬对急性脑梗死治疗临床研究分析 来自淘豆网m.daumloan.com转载请标明出处.
